Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 24 tags : Treatment save search
Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
Published: 2022-05-24 (Crawled : 01:00) - biospace.com/
ARDX | News | $6.44 -1.68% -1.63% 2.9M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ibsrela treatment tenapanor
European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer
Published: 2022-05-24 (Crawled : 15:20) - globenewswire.com
RFL 4 | $1.71 -3.93% 4.68% 11K
|
Finance
|
| O: -0.56%
H: 18.64%
C: 0.0%
cpi-613 613 treatment designation drug cancer
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
SYBX | $1.83 3.39% -1.72% 70K
|
Health Technology
|
| O: 4.13%
H: 0.0%
C: -11.11%
synb1618 treatment designation positive phenylketonuria
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
ORMP | $2.2 -5.58% -6.39% 240K
|
Health Technology
|
| O: -0.87%
H: 0.22%
C: -4.4%
treatment patent granted diabetes therapy insulin
For rare disease patients in Mainland China, hope of greater access to treatment
Published: 2022-05-24 (Crawled : 13:20) - clarivate.com
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.04%
H: 1.53%
C: 1.37%
treatment rare disease
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
Published: 2022-05-24 (Crawled : 12:20) - prnewswire.com
ORMP | $2.2 -5.58% -6.39% 240K
|
Health Technology
|
| O: -0.87%
H: 0.22%
C: -4.4%
treatment patent granted diabetes therapy insulin
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
Published: 2022-05-24 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: -4.82%
H: 1.71%
C: -7.63%
ar-1551 treatment disease eye phase 3
Global Opisthorchiasis Treatment Market Research Report 2022: Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia
Published: 2022-05-24 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -2.41%
H: 0.0%
C: -1.7%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
treatment research report market
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
ROIV | $10.36 -0.77% -0.68% 3.4M
|
Manufacturing
|
| O: 5.21%
H: 4.82%
C: 1.82%
vtama treatment fda psoriasis tapinarof plague
Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders
Published: 2022-05-24 (Crawled : 11:00) - globenewswire.com
CING M | $0.88 3.31% 4.29% 44K
|
|
| O: 4.13%
H: 0.13%
C: -10.32%
treatment
Municipal Water and Wastewater Treatment Equipment Market Size to Increase by USD 16.02 Billion from 2021 to 2026| Technavio
Published: 2022-05-24 (Crawled : 02:00) - prnewswire.com
XYL | $127.16 0.75% -0.91% 910K
|
Producer Manufacturing
|
| O: -2.06%
H: 0.0%
C: 0.0%
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
ECL | $219.21 -0.02% 0.0% 320
|
Process Industries
|
| O: -1.08%
H: 0.0%
C: 0.0%
water treatment market
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.